World EPA Congress, 2025
— Richard Dutton & Tom Kelly
Related articles
Gene therapy mini-series: Novel payment models to facilitate patient access to gene therapy
ATMPsPricing15/10/2024
Exploring alternative pricing approaches for orphan medicines
PricingRare Diseases12/03/2024
Innovative contracting for ATMPs in Europe: Recent learnings from the manufacturer experience
ATMPsPricing03/08/2023
The ‘rituximab effect’: the challenge of low-cost and off-label comparators in rare diseases
PricingRare Diseases22/03/2023